Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hutchmed (HCM) Share News

6789101112131415

Hutchinson China MediTech Starts HMPL-523 Trial For Autoimmune Disease

18th Jun 2014 07:47

LONDON (Alliance News) - Hutchison China MediTech Ltd said Wednesday its majority owned research and development company has begun the first in-human Phase I clinical trial of HMPL-523 for autoimmune diseases. Hutchinson MediPharma Ltd has begun the trial in Australia, with the aim of estab Read More

Hutchinson China MediTech Launches Phase II Lung Cancer Drug Trial

5th Jun 2014 11:22

LONDON (Alliance News) - Hutchinson China MediTech Ltd said Thursday that its majority owned research and development company has begun a Phase II clinical trial of drug fruquintinib for the treatment of non-small cell lung cancer in China. The trial is targeted at patients who have failed Read More

DIRECTOR DEALINGS: Hutchinson China MediTech Non-Executive Buys Shares

4th Jun 2014 13:39

LONDON (Alliance News) - Hutchinson China MediTech Ltd said Wednesday that Independent Non-Executive Director Christopher Nash bought 4,036 shares at 842 pence each. Following this transaction, Nash's interest in the China-based healthcare company is 0.06%. Shares in China MediTech we Read More

Hutchison China MediTech's JV Gets Rights To Six Drugs From Partner

30th May 2014 08:37

LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said Shanghai Traditional Chinese Medicine Co. Ltd has decided to grant the two companies' joint venture exclusive rights to sell six prescription drug products in China. In a statement, Chi-Med said the Shanghai Hutchison Pharmac Read More

Hutchison China And AstraZeneca Partner For Kidney Cancer Study

23rd May 2014 11:28

LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said its research and development company Hutchison MediPharma Ltd and pharmaceuticals firm AstraZeneca PLC have initiated a global phase II study to evaluate the efficacy and safety of AZD6094, Hutchison's potent and highly selective c Read More

UK MORNING BRIEFING: UK Shares Open Higher, Led By BT And Barclays

8th May 2014 07:29

LONDON (Alliance News) - UK shares have opened mostly higher Thursday ahead of interest-rate decisions by the Bank of England and European Central Bank and amid tentative signs of reduced tensions in Ukraine.<br /><br /><strong>BT</strong> and <strong>Barclays</strong> lead the FTSE 100 at the Read More

UK AGM, EGM Calendar - Week Ahead

8th May 2014 05:12

Read More

UK AGM, EGM Calendar - Week Ahead

7th May 2014 15:49

Read More

UK AGM, EGM Calendar - Week Ahead

7th May 2014 05:12

Read More

UK AGM, EGM Calendar - Week Ahead

6th May 2014 15:30

Read More

UK AGM, EGM Calendar - Week Ahead

6th May 2014 05:30

Read More

UK AGM, EGM Calendar - Week Ahead

2nd May 2014 15:15

Read More

UK AGM, EGM Calendar - Week Ahead

2nd May 2014 05:11

Read More

UK AGM, EGM Calendar - Week Ahead

1st May 2014 15:36

Read More

Hutchison China MediTech Cleared For Joint Venture With Sinopharm

17th Apr 2014 10:39

LONDON (Alliance News) - Hutchison China MediTech Ltd said Thursday that it had been granted regulatory approval in China to establish its new joint venture with Sinopharm Group Co.Ltd. The companies will have a 51% interest in the joint venture, which will be called Hutchison Whampoa Sinop Read More

Hutchison China MediTech Begins Colorectal Cancer Trial

4th Apr 2014 09:25

LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said its majority-owned research and development company Hutchison MediPharma Ltd has initiated a Phase II clinical trial in colorectal cancer patients in China for fruquintinib. Fruquintinib is the company's investigational small Read More

UK BROKER RATINGS: Canaccord Raises Weir Group Target To 3,000p

2nd Apr 2014 09:09

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />JPMORGAN RESUMES STANDARD LIFE WITH 'OVERWEIGHT' <br />----------<br />CANACCORD CUTS ABERDEEN ASSET MANAGEMENT TARGET TO 460 Read More

UK BROKER RATINGS: SocGen Raises IMI To Buy From Hold

14th Mar 2014 10:08

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />JEFFERIES CUTS G4S PRICE TARGET TO 280 (290) PENCE - 'BUY' <br />----------<br />GOLDMAN RAISES PRUDENTIAL PRICE TARGET TO 1600 Read More

UK MORNING BRIEFING: Shares Open Lower; BP Gets US Bid Approval

14th Mar 2014 08:23

LONDON (Alliance News) - Shares have opened lower Friday on geopolitical worries ahead of the weekend, despite some good news for UK companies. <br /><br />The US government on Thursday decided to lift the ban on <strong>BP</strong> from federal government contracts imposed after the Deepwater Read More

UK BROKER RATINGS: Four Brokers Raise BHP Billiton Price Target

19th Feb 2014 10:07

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />GOLDMAN RAISES HAMMERSON PRICE TARGET TO 590 (569) PENCE - 'NEUTRAL' <br />----------<br />SOCGEN RAISES BHP BILLITON PRICE T Read More

6789101112131415
FTSE 100 Latest
Value8,275.66
Change0.00